Home>Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells
Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells
- Impact factors: 9.429
- Publication: JOURNAL OF NANOBIOTECHNOLOGY
- Author:He Cong, Jaffar Ali Doulathunnisa, Qi Yuhua, Li Yumin, Sun Beicheng, Liu Rui, Sun Bo, Xiao Zhongdang
- DOI citation-doi:10.1186/s12951-023-01902-6
- Date:2023-05-18